Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation

• Main Authors: Timothy P. Gauthier (Author), Justin Wasko (Author), Nathan R. Unger (Author), Lilian M. Abbo (Author), Margaret Fernandez (Author), Laura Aragon (Author)
• Format: Book
• Published: MDPI AG, 2015-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study evaluates drug cost outcomes related to automatic therapeutic substitution of branded tobramycin solution for inhalation (TOBI®) with inhaled generic preservative-free intravenous tobramycin (PFIT). A retrospective single-center evaluation of inhaled tobramycin use from 2008 through 2012...